Qi An

3.5k total citations · 1 hit paper
135 papers, 2.2k citations indexed

About

Qi An is a scholar working on Epidemiology, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Qi An has authored 135 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 27 papers in Surgery and 24 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Qi An's work include Acute Lymphoblastic Leukemia research (17 papers), Acute Myeloid Leukemia Research (13 papers) and Cardiac pacing and defibrillation studies (10 papers). Qi An is often cited by papers focused on Acute Lymphoblastic Leukemia research (17 papers), Acute Myeloid Leukemia Research (13 papers) and Cardiac pacing and defibrillation studies (10 papers). Qi An collaborates with scholars based in China, United States and United Kingdom. Qi An's co-authors include Pramodsingh H. Thakur, John Boehmer, Rosemary Sanders, Rick W. Wright, Keith M. Baumgarten, Matthew V. Smith, Julie Y. Bishop, Robert G. Marx, Brian R. Wolf and Armando F. Vidal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Bone and Joint Surgery.

In The Last Decade

Qi An

127 papers receiving 2.2k citations

Hit Papers

A Multisensor Algorithm Predicts Heart Failure Events in ... 2017 2026 2020 2023 2017 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi An China 22 732 506 491 262 238 135 2.2k
Yu‐Jun Chang Taiwan 28 659 0.9× 370 0.7× 177 0.4× 245 0.9× 176 0.7× 150 2.4k
Camelia Cristina Diaconu Romania 30 563 0.8× 468 0.9× 371 0.8× 385 1.5× 78 0.3× 286 2.6k
Brent G. Petty United States 22 502 0.7× 470 0.9× 532 1.1× 205 0.8× 131 0.6× 56 2.3k
Giuseppe Signoriello Italy 30 507 0.7× 725 1.4× 440 0.9× 327 1.2× 51 0.2× 120 2.7k
Sadaki Inokuchi Japan 29 714 1.0× 406 0.8× 257 0.5× 548 2.1× 125 0.5× 219 3.1k
Satoshi Fujimi Japan 30 574 0.8× 935 1.8× 312 0.6× 387 1.5× 263 1.1× 126 2.9k
Jer‐Ming Chang Taiwan 28 537 0.7× 387 0.8× 766 1.6× 216 0.8× 100 0.4× 177 2.8k
Chih‐Hsiang Chang Taiwan 33 1.2k 1.6× 669 1.3× 605 1.2× 381 1.5× 60 0.3× 234 3.6k
Philipp M. Lepper Germany 32 614 0.8× 646 1.3× 355 0.7× 451 1.7× 74 0.3× 126 2.9k
Yadong Cui China 17 419 0.6× 529 1.0× 487 1.0× 151 0.6× 75 0.3× 41 2.0k

Countries citing papers authored by Qi An

Since Specialization
Citations

This map shows the geographic impact of Qi An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi An more than expected).

Fields of papers citing papers by Qi An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi An. The network helps show where Qi An may publish in the future.

Co-authorship network of co-authors of Qi An

This figure shows the co-authorship network connecting the top 25 collaborators of Qi An. A scholar is included among the top collaborators of Qi An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi An. Qi An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zuo, Jing, et al.. (2025). Potential Biomarkers and Therapeutic Targets in Hepatitis B Virus-related Acute Liver Failure: Interplay of the Ferroptosis, Autophagy and Immune Responses. International Journal of Medical Sciences. 22(4). 806–818. 2 indexed citations
2.
Lampertico, Pietro, Pavel Bogomolov, Vladimir Chulanov, et al.. (2025). Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg‐IFNα‐2a as Treatment for Chronic Hepatitis Delta. Liver International. 45(2). e70008–e70008. 3 indexed citations
3.
Shadman, Mazyar, John M. Burke, Jennifer L. Cultrera, et al.. (2025). Zanubrutinib is well tolerated and effective in patients with CLL/SLL intolerant of ibrutinib/acalabrutinib: updated results. Blood Advances. 9(16). 4100–4110. 4 indexed citations
4.
Wang, Yanqiu, et al.. (2024). A Chemical Reprogramming Approach Efficiently Producing Human Retinal Pigment Epithelium Cells for Retinal Disease Therapies. Cell Proliferation. 58(5). e13785–e13785. 2 indexed citations
5.
Wang, Zhifa, Aijun Zhang, Nan Wang, et al.. (2024). Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China. British Journal of Haematology. 204(5). 1958–1965. 5 indexed citations
6.
Chen, Jie, Min Zhao, Qi An, Wei Lan, & Bin Chen. (2024). Detection of Muscular Metastasis in a Case of Parathyroid Carcinoma Using 18F-FAPI-04 PET/CT. Clinical Nuclear Medicine. 49(10). e501–e502. 2 indexed citations
7.
Yin, Zixiao, Qi An, Shu Wang, et al.. (2023). Association between Cognitive Impairment and Freezing of Gait in Patients with Parkinson’s Disease. Journal of Clinical Medicine. 12(8). 2799–2799. 9 indexed citations
8.
An, Qi, Lu Liu, & Dandan Wang. (2023). PB2623: AVATROMBOPAG FOR THE TREATMENT OF CHILDREN WITH PERSISTENT AND CHRONIC IMMUNE THROMBOCYTOPENIA. HemaSphere. 7(S3). e96683e8–e96683e8. 1 indexed citations
14.
An, Qi, Jun Liu, Liu Y, et al.. (2020). Primary Drug-Resistance Pattern and Trend in Elderly Tuberculosis Patients in Shandong, China, from 2004 to 2019. SHILAP Revista de lepidopterología. 3 indexed citations
15.
Gardner, Roy S., Jagmeet P. Singh, B Stančák, et al.. (2018). HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events. Circulation Heart Failure. 11(7). e004669–e004669. 73 indexed citations
16.
Das, Rupali, Peng Guan, Leslee Sprague, et al.. (2016). Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis. Blood. 127(13). 1666–1675. 182 indexed citations
17.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026